BioTechne Corp (TECH)
(Delayed Data from NSDQ)
$79.63 USD
+2.58 (3.35%)
Updated May 9, 2024 04:00 PM ET
After-Market: $79.66 +0.03 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum F VGM
Brokerage Reports
Bio-Techne Corp [TECH]
Reports for Purchase
Showing records 101 - 120 ( 188 total )
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Healthy Beat, Raising Revenue Estimates, Multiple Growth Drivers
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
An Impressive ''COVID-19-Light'' Earnings Beat Underscores Commercial Execution
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Bio-Techne Corp
Industry: Medical - Biomedical and Genetics
Comprehensive Technical and Fundamental Analysis for TECH.
Provider: Stock Traders Daily
Analyst: Research Department